The association between disability and residual symptoms in depressive patients:: A 3-month follow-up

被引:0
|
作者
Oezyueksel, Banu [1 ]
Ulug, Berna [2 ]
机构
[1] Psikiyatri AD, Ozel Kercioren Hastanesl, Ankara, Turkey
[2] Psikiyatri AD, Hacettepe Tip Fak, Ankara, Turkey
关键词
depression; anxiety; disability;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: In this 3-month naturalistic follow-up we aimed to investigate depression treatment outcome and the correlation between improvement of depressive symptoms and level of disability. Method: The study included 104 patients with depression that presented to the Hacettepe Psychiatry Outpatient Clinic. The course was defined operationally using the Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, and Structured Clinical Interview for DSM-IV Axis I Disorders. The World Health Organization Disability Assessment Schedule (WHO-DAS II) was administered to determine level of disability. Patients received follow-up assessments using the some instruments 3 months after receiving antidepressant treatment. Results: Follow-up assessments showed that improvement in Hamilton Depression Rating Scale and Hamilton Anxiety Rating Scale total scores was statistically significant, and lower anxiety and depression ratings were correlated with lower disability levels. The patients that had severe depression and anxiety at the beginning of the course had residual depressive symptoms. The results showed that severity of depression was a predictor of residual symptoms in our cohort. Psychological anxiety was the most common residual symptom (consistent with other studies) and the patients with a psychological anxiety score >= 2 had higher disability levels (Z = -3.570, P < 0.05). Conclusion: Severity of depression was a predictor of residual symptoms and partial remission after a depressive episode appeared to be strongly associated with disability. These findings highlight the importance of adequate treatment of depression.
引用
收藏
页码:323 / 332
页数:10
相关论文
共 50 条
  • [31] Comparison of outcomes after 3-month methadone maintenance treatment between heroin users with and without HIV infection: a 3-month follow-up study
    Wang, Peng-Wei
    Lin, Huang-Chi
    Yen, Chia-Nan
    Yeh, Yi-Chun
    Hsu, Chih-Yao
    Chung, Kuan-Sheng
    Chang, Hsun-Cheng
    Wu, Hung-Chi
    Yen, Cheng-Fang
    HARM REDUCTION JOURNAL, 2015, 12
  • [32] Predictors for quality of life among older adults with depressive disorders: A prospective 3-month follow-up cohort study
    Wongprommate, Darawan
    Wongpakaran, Tinakon
    Pinyopornpanish, Manee
    Lerttrakarnnon, Peerasak
    Jiraniramai, Surin
    Satthapisit, Sirina
    Saisavoey, Nattha
    Wannarit, Kamonporn
    Nakawiro, Daochompu
    Tantrarungroj, Thanita
    Wongpakaran, Nahathai
    PERSPECTIVES IN PSYCHIATRIC CARE, 2022, 58 (03) : 1029 - 1036
  • [33] Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study
    Skau, Maren
    Sander, Birgit
    Milea, Dan
    Jensen, Rigmor
    JOURNAL OF NEUROLOGY, 2011, 258 (02) : 277 - 283
  • [34] Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis
    Cobo Dols, Manuel
    Beato Zambrano, Carmen
    Cabezon Gutierrez, Luis
    Chicas Sett, Rodolfo
    Blancas Lopez-Barajas, Maria Isabel
    Garcia Navalon, Francisco
    Firvida Perez, Jose Luis
    Serrano Bermudez, Gala
    Togores Torres, Pilar
    Delgado Mingorance, Ignacio
    Giraldo Marin, Alexandra
    Libran Oriol, Anna
    Paredes Lario, Alfredo
    Sanchez Maurino, Pedro
    Higuera Gomez, Oliver
    Moreno Munoz, Diana
    Jimenez Lopez, Antonio Javier
    Huerta Gonzalez, Ibone
    Sanz Yague, Almudena
    Soler Lopez, Begona
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2021, 11 (01) : 25 - 31
  • [35] Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study
    Maren Skau
    Birgit Sander
    Dan Milea
    Rigmor Jensen
    Journal of Neurology, 2011, 258 : 277 - 283
  • [36] Gains in distance walking in a 3-month follow-up poststroke: What changes?
    Pohl, PS
    Perera, S
    Duncan, PW
    Maletsky, R
    Whitman, R
    Studenski, S
    NEUROREHABILITATION AND NEURAL REPAIR, 2004, 18 (01) : 30 - 36
  • [37] Severe COVID-19-induced AKI: a 3-month follow-up
    Orieux, Arthur
    Rubin, Sebastien
    Prevel, Renaud
    Garric, Antoine
    Gruson, Didier
    Boyer, Alexandre
    CLINICAL KIDNEY JOURNAL, 2021, 14 (04) : 1289 - 1290
  • [38] Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study
    Jensen, R.
    Skau, M.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S71 - S71
  • [39] The effects of aerobic exercise on cognition in schizophrenia: A 3-month follow-up study
    Su, Chwen-Yng
    Wang, Peng-Wei
    Lin, Yi-Jean
    Tang, Tze-Chun
    Liu, Mei-Fang
    Chen, Ming-De
    PSYCHIATRY RESEARCH, 2016, 244 : 394 - 402
  • [40] Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up
    Medved, V.
    Kuzman, M. R.
    Jovanovic, N.
    Grubisin, J.
    Kuzman, T.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (08) : 915 - 922